BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24949998)

  • 21. A novel PALB2 truncating mutation in an Italian family with male breast cancer.
    Vietri MT; Caliendo G; Casamassimi A; Cioffi M; De Paola ML; Napoli C; Molinari AM
    Oncol Rep; 2015 Mar; 33(3):1243-7. PubMed ID: 25529982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.
    Ghiorzo P; Pensotti V; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bonelli L; Borgonovo G; Bruno W; Gozza A; Gargiulo S; Mastracci L; Nasti S; Palmieri G; Papadia F; Pastorino L; Russo A; Savarino V; Varesco L; Bernard L; Bianchi Scarrà G;
    Fam Cancer; 2012 Mar; 11(1):41-7. PubMed ID: 21989927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore.
    Phuah SY; Lee SY; Kang P; Kang IN; Yoon SY; Thong MK; Hartman M; Sng JH; Yip CH; Taib NA; Teo SH
    PLoS One; 2013; 8(8):e73638. PubMed ID: 23977390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PALB2 sequence variants in young South African breast cancer patients.
    Sluiter M; Mew S; van Rensburg EJ
    Fam Cancer; 2009; 8(4):347-53. PubMed ID: 19333784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
    Zhang F; Fan Q; Ren K; Andreassen PR
    Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].
    Janatová M; Borecká M; Soukupová J; Kleiblová P; Stříbrná J; Vočka M; Zemánková P; Panczak A; Veselá K; Souček P; Foretová L; Kleibl Z
    Klin Onkol; 2016; 29 Suppl 1():S31-4. PubMed ID: 26691940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.
    Teo ZL; Park DJ; Provenzano E; Chatfield CA; Odefrey FA; Nguyen-Dumont T; ; Dowty JG; Hopper JL; Winship I; Goldgar DE; Southey MC
    Breast Cancer Res; 2013 Feb; 15(1):R17. PubMed ID: 23448497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A PALB2 germline mutation associated with hereditary breast cancer in Italy.
    Papi L; Putignano AL; Congregati C; Piaceri I; Zanna I; Sera F; Morrone D; Genuardi M; Palli D
    Fam Cancer; 2010 Jun; 9(2):181-5. PubMed ID: 19763884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.
    Buisson R; Dion-Côté AM; Coulombe Y; Launay H; Cai H; Stasiak AZ; Stasiak A; Xia B; Masson JY
    Nat Struct Mol Biol; 2010 Oct; 17(10):1247-54. PubMed ID: 20871615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PALB2 mutations in familial breast and pancreatic cancer.
    Hofstatter EW; Domchek SM; Miron A; Garber J; Wang M; Componeschi K; Boghossian L; Miron PL; Nathanson KL; Tung N
    Fam Cancer; 2011 Jun; 10(2):225-31. PubMed ID: 21365267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.
    Cecener G; Guney Eskiler G; Egeli U; Tunca B; Alemdar A; Gokgoz S; Tasdelen I
    Mol Biol Rep; 2016 Nov; 43(11):1273-1284. PubMed ID: 27573125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.
    Tischkowitz M; Sabbaghian N; Ray AM; Lange EM; Foulkes WD; Cooney KA
    Prostate; 2008 May; 68(6):675-8. PubMed ID: 18288683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
    Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
    Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
    Hellebrand H; Sutter C; Honisch E; Gross E; Wappenschmidt B; Schem C; Deissler H; Ditsch N; Gress V; Kiechle M; Bartram CR; Schmutzler RK; Niederacher D; Arnold N; Meindl A
    Hum Mutat; 2011 Jun; 32(6):E2176-88. PubMed ID: 21618343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel germline PALB2 truncating mutations in African American breast cancer patients.
    Zheng Y; Zhang J; Niu Q; Huo D; Olopade OI
    Cancer; 2012 Mar; 118(5):1362-70. PubMed ID: 21932393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous mutations in PALB2 cause DNA replication and damage response defects.
    Nikkilä J; Parplys AC; Pylkäs K; Bose M; Huo Y; Borgmann K; Rapakko K; Nieminen P; Xia B; Pospiech H; Winqvist R
    Nat Commun; 2013; 4():2578. PubMed ID: 24153426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer proteins PALB2 and BRCA2 stimulate polymerase η in recombination-associated DNA synthesis at blocked replication forks.
    Buisson R; Niraj J; Pauty J; Maity R; Zhao W; Coulombe Y; Sung P; Masson JY
    Cell Rep; 2014 Feb; 6(3):553-64. PubMed ID: 24485656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.